Back to search results

Omalizumab Weight-Based Dosing Efficacy Trial

Abroad (travel likely)RecruitingPHASE2

Conditions

Allergies · Food Allergy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Massachusetts General Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Jannat Gill) · Jgill0@mgh.harvard.edu · 614-643-8683
    Contact: Principal Investigator (Wayne Shreffler, MD)

  • University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States

    Contact: Study coordinator (Lauren Herlihy) · lherlihy@unc.edu

  • University of Texas Southwestern, Dallas, Texas, United States

    Contact: Study coordinator (Dolores Santoyo) · Dolores.Santoyo@UTSouthwestern.edu
Study leads

  • Wayne Shreffler, MD, PhD

    Principal Investigator

    Massachusetts General Hospital

View source on ClinicalTrials.gov(opens in a new tab)